Pharmagant
0669.844.683 · rovalta.com · 23/09/2026
NORMAL SITUATION
Pharmagant
Financial year 2021 · closed on 31/12/2021
Net result
-5,8 k €
-266.7% YoY
Gross margin
-4,5 k €
-1754.2% YoY
Equity
21,9 k €
-20.9% YoY
Company — Normal situation.
Overview
What does Pharmagant do?
Pharmagant is a company registered in Belgium.
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0669.844.683
Legal form
Public limited company
Contributed capital
110 969,00 €
Latest accounts
31/12/2021
Signals
Solid equityGood liquidity
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 5 financial years
| 2021 | 2020 | 2019 | 2018 | 2017 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -4,5 k € | -1754% | -241,2 € | +98.4% | -14,8 k € | -55.0% | -9,6 k € | +81.9% | -52,8 k € |
| EBITDA | -4,9 k € | -598% | -708 € | +95.4% | -15,5 k € | -55.0% | -10 k € | +81.4% | -53,8 k € |
| Operating result | -5,6 k € | -299% | -1,4 k € | +91.3% | -16,2 k € | -51.3% | -10,7 k € | +80.4% | -54,5 k € |
| Net result | -5,8 k € | -267% | -1,6 k € | +90.3% | -16,3 k € | -51.5% | -10,8 k € | +80.3% | -54,6 k € |
| Balance sheet | |||||||||
| Equity | 21,9 k € | -20.9% | 27,7 k € | -5.4% | 29,3 k € | -65.4% | 84,7 k € | -11.3% | 95,4 k € |
| Total assets | 23,4 k € | -24.9% | 31,1 k € | -30.6% | 44,8 k € | -47.7% | 85,7 k € | -15.1% | 101 k € |
| Cash | 22,3 k € | -15.6% | 26,4 k € | -21.8% | 33,7 k € | -52.2% | 70,5 k € | -20.0% | 88,2 k € |
| Debts | 1,4 k € | -57.6% | 3,4 k € | -76.0% | 14 k € | +1207% | 1,1 k € | -80.8% | 5,6 k € |
Governance
Board of directors
Seen on filing of 31/12/2021 · 3 active · 9 ended
Financials
Annual accounts
Full financial information
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Micro model |
| Start of the financial year | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 | 23/01/2017 |
| Closing of the financial year | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 | 31/12/2017 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 24/08/2022 | 31/08/2021 | 30/09/2020 | 31/08/2019 | 31/08/2018 |
| General meeting | 25/06/2022 | 26/06/2021 | 31/08/2020 | 29/06/2019 | 30/06/2018 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
5 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2021 | 25/06/2022 | 24/08/2022 | Dutch | |
| Abridged model | 31/12/2020 | 26/06/2021 | 31/08/2021 | Dutch | |
| Abridged model | 31/12/2019 | 31/08/2020 | 30/09/2020 | Dutch | |
| Abridged model | 31/12/2018 | 29/06/2019 | 31/08/2019 | Dutch | |
| Micro model | 31/12/2017 | 30/06/2018 | 31/08/2018 | Dutch |
Valuation
Estimate
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2021 · 3 active · 9 ended
Shareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2021Annual accounts 2021-5,8 k €↓
- 2020Annual accounts 2020-1,6 k €↑
- 2019Annual accounts 2019-16,3 k €↓
- 2018Annual accounts 2018-10,8 k €↑
- 2017Annual accounts 2017-54,6 k €